Actineer™ Inc. is a joint venture company between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM) dedicated to advancing Ac-225 technologies, quickly securing supply, and producing industrial-scale quantities of this valuable, rare medical radioisotope for the treatment of cancer. Founded in October 2023, Actineer™ Inc. together with its strong supply chain collaborators will progress Ac-225 development, production and processing technologies to establish short-term production capabilities that will significantly boost international supplies, while working long-term towards the construction of a new Actinium Production Facility (APF) in Canada. The joint venture’s mission is to fulfil the unmet global manufacturing and production needs of this coveted radioisotope with significant potential in the fight against cancer.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Jobs
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.actineer.com/
- Keywords
- Chalk River.
Actineer, Inc. Questions
Actineer, Inc.'s website is https://www.actineer.com/
Actineer, Inc.'s LinkedIn profile is https://www.linkedin.com/company/actineer-inc
Actineer, Inc. has
3 employees.
View email and phone details for 3
employees at Actineer, Inc..
Actineer, Inc.'s industry is
Pharmaceutical Manufacturing
Actineer, Inc.'s top competitors are
Mitelos,
Telix Pharmaceuticals Limited,
Radiopharm Theranostics,
Ariceum Therapeutics,
Canadian Nuclear Laboratories,
Nusano,
Lantheus,
Itm Isotope Technologies Munich Se,
Atomvie Global Radiopharma Inc.,
Global Morpho Pharma.
Actineer, Inc.'s categories are Pharmaceutical Manufacturing
Actineer, Inc.'s founding year is 2023
